510(k) device
Praxiject SP 0.9% NaCl
Medxl, Inc. · Saline, Vascular Access Flush (NGT, Class II) · First FDA decision Feb 27, 2024, newest Feb 27, 2024Vascular access
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "Praxiject SP 0.9"
MAUDE reports
2
Brand "Praxiject SP 0.9", since 2015
PubMed studies
0
Mentioning "Praxiject SP 0.9"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Praxiject SP 0.9% NaCl
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Praxiject SP 0.9% NaCl510(k)
K233623 · Decided Feb 27, 2024 · 106 days after receipt
Device type: Saline, Vascular Access Flush (NGT) · Hospital Medicine & Nursing
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Non-Invasive Peripheral Venous Vascular and Hemodialysis Access StudiesLocal determinationIn effectL35751WPS Insurance CorporationUpdated Feb 20, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Praxiject SP 0.9", any status and sponsor, newest update first.
No registered device study names "Praxiject SP 0.9".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Praxiject SP 0.9", and for the whole product code for context.
This brand
2 reports: 2 malfunction, 0 injury, 0 death
Whole product code NGT
3,043 reports: 2,791 malfunction, 207 injury, 23 death
Newest reports for this brand
- PRAXIJECT SP 0.9% NACLMalfunction
20999735 · Received Dec 23, 2024 · Event dated Dec 3, 2024
Device type: Saline, Vascular Access Flush (NGT)
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
1 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Praxiject SP 0.9"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NGT.
- 0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP SyringeBecton, Dickinson and Company · 510(k) 2025
- Praxiject 0.9% NaClMedxl, Inc. · 510(k) 2023
- AMSafe Pre-Filled Normal Saline Flush SyringeAmsino International, Inc. · 510(k) 2022
- 0.9% Sodium Chloride Injection, USP, Pre-filled COP SyringeMedline Industries, Inc. · 510(k) 2019
- 0.9% Sodium Chloride Flush SyringeAm USA · 510(k) 2014
- 0.9% Sodium Chloride Injection Usp Bd Posiflush Flush Syringe, Sf Flush SyringeBecton, Dickinson & CO · 510(k) 2013
- Am Usa 0.9% Sodium Chloride Flush SyringeAm USA · 510(k) 2012
- Medefil's Normal Saline I.v. Flush SyringeMedefil, Inc. · 510(k) 2010
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.